NISA INVESTMENT ADVISORS, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2022$126,000
-38.2%
84,368
-29.7%
0.00%
-50.0%
Q4 2021$204,000
-52.2%
120,0000.0%0.00%
-33.3%
Q3 2021$427,000
-38.0%
120,0000.0%0.00%
-25.0%
Q2 2021$689,000
+10.6%
120,0000.0%0.00%0.0%
Q1 2021$623,000
+117.1%
120,0000.0%0.00%
+100.0%
Q4 2020$287,000
+9466.7%
120,000
+7519.0%
0.00%
Q2 2020$3,000
+50.0%
1,575
+71.2%
0.00%
Q1 2020$2,0009200.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders